BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Embryo
,
Biofuel
,
Rapamycin
,
rs2300478
,
SLC12A1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pr 39
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Regulation of endometrial bleeding by uNK cells
Livers of rats exposed to 27 agents with different mechanisms of action for toxicity
Expression profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice
Livers from wildtype Sprague-Dawley rats exposed to 27 chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39…
Quantification of the PR-39 cathelicidin compound in porcine blood by matrix-assisted laser desorpti…
Antimicrobial and immunomodulatory activities of PR-39 derived peptides.
Expression pattern of porcine antimicrobial peptide PR-39 and its induction by enterotoxigenic Esche…
PR-39, a porcine host defence peptide, is prominent in mucosa and lymphatic tissue of the respirator…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Dise…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ